STAU2 (Staufen double-stranded RNA binding protein 2) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation and cellular homeostasis. STAU2 functions primarily through double-stranded RNA binding and mRNA trafficking, with particular importance in neuronal contexts where it facilitates microtubule-dependent transport of mRNAs from cell bodies to dendrites 1. The protein operates through multiple mechanisms including Staufen-mediated mRNA decay (SMD), where it forms complexes with UPF1 helicase to regulate mRNA stability and degradation 2. STAU2 also interacts directly with UPF1 in an RNA-independent manner and can differentially affect mRNA fate in a cell type-dependent manner 3. Disease relevance is significant, as STAU2 is overexpressed in neurodegenerative diseases including ALS and spinocerebellar ataxia, where it activates mTOR signaling and stress granule formation 1. Additionally, STAU2 promotes cancer progression and metastasis through regulation of EMT pathways in pancreatic cancer 4. Clinically, STAU2 serves as a potential biomarker for breast cancer risk assessment through lymphocyte quantification 5, and its expression is regulated by DNA damage responses through the ATR signaling pathway 6.